Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Jan. 01, 2021 $ 2 $ 129,725 $ (72,258) $ 57,469
Balance (in Shares) at Jan. 01, 2021 23,264,637      
Exercise of stock options [1] 23 23
Exercise of stock options (in Shares) 12,646      
Exercise of warrant [1]  
Exercise of warrant (in Shares) 362,383      
Issuance of Common Stock under Open Market Sales Agreement [1] 4,334 4,334
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 601,674      
Stock-based compensation expenses 530 530
Net loss (8,402) (8,402)
Balance at Mar. 31, 2021 $ 2 134,612 (80,660) 53,954
Balance (in Shares) at Mar. 31, 2021 24,241,340      
Exercise of stock options [1] 78 78
Exercise of stock options (in Shares) 55,246      
Issuance of Common Stock under Open Market Sales Agreement [1] 801 801
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 132,490      
Stock-based compensation expenses 1,095 1,095
Net loss (7,336) (7,336)
Balance at Jun. 30, 2021 $ 2 136,586 (87,996) 48,592
Balance (in Shares) at Jun. 30, 2021 24,429,076      
Exercise of stock options [1] 20   20
Exercise of stock options (in Shares) 11,653      
Issuance of Common Stock under Open Market Sales Agreement [1] 53   53
Issuance of Common Stock under Open Market Sales Agreement (in Shares) 9,800      
Issuance of Common Stock under securities purchase agreement (“SPA”), net of $1,235 issuance costs [1] 13,765   13,765
Issuance of Common Stock under securities purchase agreement (“SPA”), net of $1,235 issuance costs (in Shares) 3,750,000      
Stock-based compensation expenses   1,027   1,027
Net loss     (10,031) (10,031)
Balance at Sep. 30, 2021 $ 2 151,451 (98,027) 53,426
Balance (in Shares) at Sep. 30, 2021 28,200,529      
Balance at Dec. 31, 2021       $ 47,535
Exercise of stock options (in Shares)      
Net loss       $ (22,431)
Balance at Sep. 30, 2022 $ 2 157,471 (130,915) 26,558
Balance (in Shares) at Sep. 30, 2022 29,976,582      
Balance at Jan. 01, 2022 $ 2 156,017 (108,484) 47,535
Balance (in Shares) at Jan. 01, 2022 29,747,538      
Issuance of Common Stock under Open Market Sales Agreement [2] [1] 37 37
Issuance of Common Stock under Open Market Sales Agreement (in Shares) [2] 27,171      
Stock-based compensation expenses 615 615
Net loss (8,169) (8,169)
Balance at Mar. 31, 2022 $ 2 156,669 (116,653) 40,018
Balance (in Shares) at Mar. 31, 2022 29,774,709      
Stock-based compensation expenses 184 184
Proceeds on account of shares   19   19
Net loss (7,482) (7,482)
Balance at Jun. 30, 2022 $ 2 156,872 (124,135) 32,739
Balance (in Shares) at Jun. 30, 2022 29,774,709      
Issuance of Common Stock under Open Market Sales Agreement [2] [1] 236   236
Issuance of Common Stock under Open Market Sales Agreement (in Shares) [2] 201,873      
Stock-based compensation expenses   363   363
Net loss     (6,780) (6,780)
Balance at Sep. 30, 2022 $ 2 $ 157,471 $ (130,915) $ 26,558
Balance (in Shares) at Sep. 30, 2022 29,976,582      
[1] Less than $1.
[2] See Note 5A.